Hmm...I am pretty nervous about the numbers, but ANO have the benefit of the 'Lev put' (what will this cost minority shareholders?). ANO has been hit hard by COVID-19. Key takeaways:
1) Receivables over 61 days has ballooned to $3.4 M, up from $171K in prior year. A key distributor is carrying excess product and is unable to onsell it, and the company has agreed to extended payment terms, which are currently being met.
2) Inventories have ballooned to $6.4 M, up from $1.1 M in prior year. CEO reports sales will be down over the next few months as customers reduce inventory, and ANO are building up inventory in anticipation of a v-shaped sunscreen recovery by Q4 2021.
3) Balance sheet as at the end of year has $260 k in cash. Lev will support ANO's liquidity requirements. The Lev put is in place.
4) ANO has set a goal of capturing 2-3% of active ingredient market share by FY2024. SUnscreen market forecast to be $24 Billion (USD?). If 5% of the market is active ingredients, that equates to a target revenue of around $50 M - Let me know if my estimate is wrong please, as it seems a little lower than I expected.
5) Reportedly increasing competition from Everzinc. This may result in pressure on margins.???
6) Forecast for HY2021 is for it to be better than HY FY2019. No guidance provided, contrary to last year, this may mean revenue is expected to be flat FY2021????
7) 22 employees on Jobkeeper and no bonuses are to be paid, board and management wage freeze.
8) Sales up to February were running at around $2 Million per month, post February, sales slumped to $0.4 M per month.
9) ANO are expecting the sunscreen market to begin to recover by Q4 2021, and are positioning supplies and inventories for an anticipated ramp up in demand as manufacturers rebuild depleated stockpiles.
It looks pretty bleak over the next 6 months, and if there is a vaccine / or a second European wave doesn't hit hard, there may be green shoots in H2 2021.
DISC - I hold.